Sphera Funds Management Ltd. Axsome Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 10, 2018	SELL	$2.35 - $5.6 $707,350 - $1.69 Million	-301,000 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$4.45 - $6.2 $890,000 - $1.24 Million	-200,000 Reduced 39.92%	301,000 $1.69 Million
Q3 2017 Nov 09, 2017	BUY	$4.65 - $6.1 $2.33 Million - $3.06 Million	501,000	501,000 $2.78 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.